Observational analysis demonstrates enhanced detection of glutamic acid and glutamine in terahertz biosensing, indicating improved diagnostic capabilities.
Metasurface biosensing confronts a significant challenge in simultaneously achieving broadband response, high quality-factor (Q-factor), and ultrahigh sensitivity for specific trace-analyte detection at terahertz (THz) frequencies. Recently, quasi-bound states in the continuum (QBICs) metasurfaces provided enhanced light–matter interactions and ultrahigh sensitivity in narrow resonant bands. In this work, an angle-scanning QBIC metasurface array pixelated with just 5 × 5 scaling units is proposed to achieve an ultra-broad spectrum from 1 to 2.8 THz for fingerprint bio-detection. The symmetry-protected QBIC is excited by breaking the symmetry of copper block dimer resonator structures, achieving a Q-factor of 20 and a sensitivity of 500 GHz/RIU. A spectral step of approximately 10 GHz is demonstrated in this approach, and glutamic acid and glutamine are specifically detected, with detection limits reaching 15.4 μg/cm2 and 14.7 μg/cm2. This design provides a novel approach for achieving ultra-wideband, specific, and highly sensitive detection. This capability offers an efficient strategy for monitoring tumor metabolic biomarkers and paves the way for applications in early diagnosis and advanced broadband THz detection.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: